Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cuhk-pioneers-dna-chip-for-prenatal-diagnosis-in-hk
https://www.med.cuhk.edu.hk/press-releases/cuhk-pioneers-dna-chip-for-prenatal-diagnosis-in-hk

CUHK Pioneers DNA Chip for Prenatal Diagnosis in HK

The Department of Obstetrics and Gynaecology at The Chinese University of Hong Kong (CUHK) is one of the leaders for first trimester screening for Down syndrome in Hong Kong. Since the introduction of ultrasound nuchal translucency (NT) measurement in the OSCAR (One-Stop Clinic for Assessment of Risk) clinic, the Department has been servicing a substantially increasing demand for first trimester screening. Since July 2010, the Hospital Authority has started to offer this screening test to all Hong Kong pregnant women free of charge. 

 

Increased NT during first trimester is a recognized sensitive marker for Down syndrome, but requires further confirmation by which fetal karyotyping is highly recommended. About two-third of these fetuses would have a normal karyotype result, yet at least 10% of them would have structural abnormalities or neurodevelopmental delay, which is known to be associated with a wide array of syndromic disorders and genetic diseases. Previously, making a specific diagnosis of these syndromicand genetic diseases prenatally is difficult, as many of them are linked to submicroscopic chromosomal abnormalities that are undetectable by conventional karyotyping. Over 100 diseases have been reported to be associated with an increased NT, thus a better and more comprehensive technique is of essence in order to diagnose or exclude these syndromic and genetic diseases prenatally. 

 

Microarray based comparative genomic hybridization (array CGH, also DNA chip) can detect chromosomal aberrations invisible by light microscopy karyotyping analysis. The Department of Obstetrics and Gynaecology at CUHK is the ever-first to introduce the DNA chip in prenatal diagnosis in 2009 in Hong Kong and the Asia Pacific region. Fetal DNA chipis a specially designed diagnostic chip with a high resolution to detect common micro-deletion and microduplication syndromes, which would not be detected by conventional karyotyping analysis.

 

(from left) Prof. Tze Kin LAU, Clinical Professor (honorary); Prof. Tak Yeung LEUNG and Prof. Richard Kwong Wai CHOY, Associate Professor, Department of Obstetrics and Gynaecology, CUHK, show the DNA chip.

(from left) Prof. Tze Kin LAU, Clinical Professor (honorary); Prof. Tak Yeung LEUNG and Prof. Richard Kwong Wai CHOY, Associate Professor, Department of Obstetrics and Gynaecology, CUHK, show the DNA chip.

Over the past 6 months, researchers led by Professor Tak Yeung LEUNG and Professor Richard Kwong Wai CHOY at CUHK analyzed the results of DNA chip and karyotyping to investigate the presence of submicroscopic chromosomal aberration in a cohort of fetuses that had increased NT and normal karyotype. It was demonstrated for the first time that a significant portion of fetuses with high NT (4/48; 8.3%) carried submicroscopic chromosomal aberration considered to be fatal or associated with severe congenital abnormalities that could not be detected by karyotype analysis. This additional information is extremely valuable to parents during their decision making process for future pregnancies. 

 

In conclusion, CUHK has successfully introduced a new technique — DNA chip for prenatal diagnosis. DNA chip enhances the sensitivity and accuracy of diagnosing lethal and severe congenital disorders like Mowat Wilson syndrome through a precise and delicate measurement of DNA copy number changes in human genome. It has helped to realize successful prenatal diagnosis of many rare but clinically significant submicroscopic chromosomal abnormalities, giving more comprehensive, higher resolution and earlier results than conventional karyotype analysis. This research finding has been published in the international journal Ultrasound Obstet Gynecol.

More Press Releases

CUHK Pioneers Whole Genome Sequencing for Prenatal Diagnosis in Hong Kong

CUHK Pioneers Whole Genome Sequencing for Prenatal Diagnosis in Hong Kong

Research
CUHK and FPAHK launch the Jockey Club Genetic Carrier Screening Programme for High Risk Couples

CUHK and FPAHK launch the Jockey Club Genetic Carrier Screening Programme for High Risk Couples

Health Campaign
CUHK Pioneers Whole Genome Sequencing for Identifying the Chromosomal Abnormalities in Couples with Recurrent Miscarriages

CUHK Pioneers Whole Genome Sequencing for Identifying the Chromosomal Abnormalities in Couples with Recurrent Miscarriages

Research
CUHK Validates the Enhanced UK Fetal Medicine Foundation’s Triple Test Can Double the Detection Rate of Preterm Preeclampsia in Asian Pregnant Women

CUHK Validates the Enhanced UK Fetal Medicine Foundation’s Triple Test Can Double the Detection Rate of Preterm Preeclampsia in Asian Pregnant Women

Research
CUHK and Queen Mary University of London lead largest international trial of time-lapse imaging systems for embryo incubation in IVF Technology found to enjoy no advantage over conventional methods

CUHK and Queen Mary University of London lead largest international trial of time-lapse imaging systems for embryo incubation in IVF Technology found to enjoy no advantage over conventional methods

Research
CUHK leads multi-centre Asian study showing that an early screen-and-prevent strategy for preterm preeclampsia is effective at lowering risk of complications for high-risk women by 41%  Pilot service at Prince of Wales Hospital showed promising outcome

CUHK leads multi-centre Asian study showing that an early screen-and-prevent strategy for preterm preeclampsia is effective at lowering risk of complications for high-risk women by 41% Pilot service at Prince of Wales Hospital showed promising outcome

Research
CU Medicine’s Assisted Reproductive Technology (ART) Unit preserves the reproductive ability of cancer patients in Hong Kong

CU Medicine’s Assisted Reproductive Technology (ART) Unit preserves the reproductive ability of cancer patients in Hong Kong

Research
CUHK finds that a booster vaccine dose is effective in retriggering antibodies in breast milk that protect babies

CUHK finds that a booster vaccine dose is effective in retriggering antibodies in breast milk that protect babies

Research
CUHK-Baylor Study Proves Aspirin Reduces the Risk of Preeclampsia by Decelerating the Metabolic Clock of Gestation

CUHK-Baylor Study Proves Aspirin Reduces the Risk of Preeclampsia by Decelerating the Metabolic Clock of Gestation

Research
CU Medicine Study Shows Recovered Mothers Transfer COVID-19 Antibodies to Newborn Babies

CU Medicine Study Shows Recovered Mothers Transfer COVID-19 Antibodies to Newborn Babies

Research
CUHK Proves Modified HIFU Treatment Effective for Treating Uterine Fibroids

CUHK Proves Modified HIFU Treatment Effective for Treating Uterine Fibroids

Research
The Helmsley Charitable Trust Funds Asian Research into Babies’ Gut Microbiota and Crohn’s Disease

The Helmsley Charitable Trust Funds Asian Research into Babies’ Gut Microbiota and Crohn’s Disease

Research
Chinese Women with Polycystic Ovarian Syndrome have 4-fold Higher Risk of Developing Diabetes

Chinese Women with Polycystic Ovarian Syndrome have 4-fold Higher Risk of Developing Diabetes

Research
CUHK Studies Alert Mothers to Pregnancy Weight Gain

CUHK Studies Alert Mothers to Pregnancy Weight Gain

Research
CUHK Recommends Oral Glucose Tolerance Test for All Pregnant Women Study Reveals Children of Women with Gestational Diabetes Mellitus Have 3-Fold Diabetes Risk

CUHK Recommends Oral Glucose Tolerance Test for All Pregnant Women Study Reveals Children of Women with Gestational Diabetes Mellitus Have 3-Fold Diabetes Risk

Research
CUHK Launches World’s First Study on Ovum Ageing and Female Infertility by Using Single-Cell Genomics Technology

CUHK Launches World’s First Study on Ovum Ageing and Female Infertility by Using Single-Cell Genomics Technology

Research
CUHK Launches Newborn Add-on Test for Congenital Adrenal Hyperplasia Supported by Joshua Hellmann Foundation for Orphan Disease

CUHK Launches Newborn Add-on Test for Congenital Adrenal Hyperplasia Supported by Joshua Hellmann Foundation for Orphan Disease

Donation
CUHK Reveals Hepatitis B Prevalence Among Pregnant Women Remains High Despite More Than 25 Years of Universal Hepatitis B Vaccination

CUHK Reveals Hepatitis B Prevalence Among Pregnant Women Remains High Despite More Than 25 Years of Universal Hepatitis B Vaccination

Research
CUHK Reveals Vasopressin Injection Can Reduce Risks of Hysteroscopic Myomectomy

CUHK Reveals Vasopressin Injection Can Reduce Risks of Hysteroscopic Myomectomy

Research
CUHK and Joshua Hellmann Foundation for Orphan Disease Jointly Launch Territory’s First Newborn Metabolic Screening Program

CUHK and Joshua Hellmann Foundation for Orphan Disease Jointly Launch Territory’s First Newborn Metabolic Screening Program

Donation
CUHK Introduces Hong Kong's First Fragile X Carrier Screening

CUHK Introduces Hong Kong's First Fragile X Carrier Screening

Clinical service
CUHK and US Experts Collaborate to Provide Clinical Genetic Training to Set up The Territory's First One-Stop Outpatient Genetic Clinic

CUHK and US Experts Collaborate to Provide Clinical Genetic Training to Set up The Territory's First One-Stop Outpatient Genetic Clinic

International collaboration

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.